The liquidity position of The company remains strong with our cash and investments at the holding company at $1,200,000,000 at September 30, 2023, which was principally held in cash and short dated investments and access to our fully undrawn $2,000,000,000 unsecured revolving credit At September 30, 2023, the excess of fair value over carrying value of investments in non insurance associates and market traded consolidated non insurance subsidiaries was $601,000,000 compared to $310,000,000 at December 31, 2022. That pretax excess of $601,000,000 is not reflected in our book value per share, but is regularly reviewed by management as an indicator of investment performance. Please refer to the MD and A on Page 67 for additional details. The holding company has no significant holding company debt maturities until August 2024 and our total debt Total cap ratio, excluding the non insurance companies, improved to 21.6% at September 30, 2023, compared to 23.7 percent at December 31, 2022, principally as a result of very strong net earnings reported in the 1st 9 months of 2023 of just under the $3,100,000,000 that reflected the underwriting profit of $943,000,000 interest and dividends of just under $1,400,000,000 and a share of profit of associates of 895,000,000 And lastly, our common shareholders' equity increased by $2,500,000,000 to 20 point at September 30, 2023, up from the $17,800,000,000 at December 31, 2022, and that was principally as a result of our net earnings in the 1st 9 months of 'twenty 3 of the $3,100,000,000 that was partially offset by payments on our common and preferred share dividends of $282,000,000 and we purchased approximately 258,000 subordinate voting shares for cancellation for cash consideration of 180,000,000 approximately $698,000 per share with $78,000 purchased in the Q3 of 2020 3 for cash consideration of $65,000,000 That concludes my remarks for the Q3 of 2023, and I'll pass the call back over to